Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

AP-MS analysis using Flp-In-293 cells

ABSTRACT: AP-MS analysis using Flp-In-293 cells used as a control

INSTRUMENT(S): LTQ

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Michael P. Washburn

PROVIDER: MSV000085212 | MassIVE | Wed Apr 01 07:39:00 BST 2020

SECONDARY ACCESSION(S): PXD018319

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Stable and inducible expression of Fbxo25 in Flp-In-293 cells: control vs. tetracycline treatment

Project description:Expression profile of human Flp-In-293-WT-FBXO25 or Flp-In-293-∆F-FBXO25 cells comparing non treated cells vs. tetraciclyne treated for 24 and 48 hours. Flp-In-293-∆F-FBXO25 cells when induced express the non functional protein (without F-box domain). The objective of the study was to identify genes up or down-regulated when Fbxo25 wild-type or Fbxo25 lacking F-box domain is superexpressed.

2012-05-15 | GSE37380 | GEO

AP-MS analysis using Flp-In 293 cells stably expressing Halo-SAP30L

Project description:AP-MS analysis using Flp-In 293 cells stably expressing Halo-SAP30L

2017-07-18 | MSV000081352 | MassIVE

AP-MS analysis using Flp-In 293 cells stably expressing Halo-SUDS3

Project description:AP-MS analysis using Flp-In 293 cells stably expressing Halo-SUDS3

2017-07-18 | MSV000081349 | MassIVE

AP-MS analysis using Flp-In 293 cells stably expressing MORF4L1-HaloTag

Project description:AP-MS analysis using Flp-In 293 cells stably expressing MORF4L1-HaloTag

2020-03-10 | MSV000085076 | MassIVE

AP-MS analysis using Flp-In 293 cells stably expressing Halo-SAP30

Project description:AP-MS analysis using Flp-In 293 cells stably expressing Halo-SAP30

2017-07-19 | MSV000081359 | MassIVE

Stable and inducible expression of Fbxo25 in Flp-In-293 cells: control vs. tetracycline treatment

Project description:Expression profile of human Flp-In-293-WT-FBXO25 or Flp-In-293-M-bM-^HM-^FF-FBXO25 cells comparing non treated cells vs. tetraciclyne treated for 24 and 48 hours. Flp-In-293-M-bM-^HM-^FF-FBXO25 cells when induced express the non functional protein (without F-box domain). The objective of the study was to identify genes up or down-regulated when Fbxo25 wild-type or Fbxo25 lacking F-box domain is superexpressed. Flp-In-293 WT and M-bM-^HM-^FF cells with and without tetracycline treatment. Two timepoints, two replicates each.

2012-05-14 | E-GEOD-37380 | biostudies-arrayexpress

AP-MS analysis using Flp-In-293 cells stably expressing SAP30L with N-terminal HaloTag

Project description:AP-MS analysis using Flp-In-293 cells stably expressing SAP30L with N-terminal

2020-03-30 | MSV000085198 | MassIVE

AP-MS analysis using Flp-In-293 cells stably expressing SUDS3 with N-terminal HaloTag

Project description:AP-MS analysis using Flp-In-293 cells stably expressing SUDS3 with N-terminal HaloTag

2020-03-30 | MSV000085196 | MassIVE

AP-MS analysis using Flp-In-293 cells stably expressing HDAC2 with C-terminal HaloTag

Project description:AP-MS analysis using Flp-In-293 cells stably expressing HDAC2 with C-terminal HaloTag

2020-03-27 | MSV000085177 | MassIVE

AP-MS analysis using Flp-In-293 cells stably expressing PHF12 with N-terminal HaloTag

Project description:AP-MS analysis using Flp-In-293 cells stably expressing PHF12 with N-terminal HaloTag